Project Grant HT94252510987
Award Date 9/30/25
Completion Date 9/29/28
Dollars Obligated $865K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78216, USA
Similar Awards
- The federal Project Grant award in the amount of $1,845,076.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The funding supports the Metis Foundation, a non-profit organization in San Antonio, Texas, to develop novel therapeutics that target innate immune responses for treating multiple organ failure in severe polytrauma during prolonged casualty care. The grant, with a performance period from November 1, 2024 to...
- The Department of Defense (DOD) Defense Health Agency awarded a $267,544 Project Grant to the Metis Foundation in San Antonio, Texas under the Military Medical Research and Development program (CFDA 12.420). The grant provides funding from September 1, 2025 through August 31, 2028 to support research on the therapeutic effects of a peroxisome proliferator-activated receptor alpha agonist on combat-induced proliferative vitreoretinopathy. Metis Foundation, a non-profit organization focused on...
- The federal Project Grant award of $1,034,071 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research by the Metis Foundation on "PROSTATE-SPECIFIC ANTIANDROGEN THERAPY FOR LOCALIZED PROSTATE CANCER." The research aims to develop innovative prostate cancer therapies, building upon Metis Foundation's expertise in conducting medical research, education, and project management support for the military health...
- The Defense Health Agency awarded a $398,107 Cooperative Agreement to the Metis Foundation, a non-profit organization, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year project to develop a multi-modal approach to reduce vascularized composite allotransplantation (VCA) immunogenicity and improve functional outcomes. The Metis Foundation has an extensive history providing medical research, products, and services through prime and sub...
- This $1,097,466 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of portable integrated optic biosensors. These biosensors are intended to help identify early indications of potential loss of native tissue in the reconstruction of complex upper extremity amputations. The 2-year grant awarded to the Metis Foundation, a non-profit research organization, will fund the research, development, and...
- The Defense Health Agency awarded a $264,000 cooperative agreement to the Metis Foundation from September 30, 2022 to September 29, 2025 under the Military Medical Research and Development program (CFDA 12.420). The award will support the Metis Foundation's ACTIVE REJECTION MICRO-PATCH SURVEILLANCE (ARMS) SYSTEM FOR VASCULARIZED COMPOSITE ALLOGRAFTS project located in San Antonio, TX. Through this funding, the Metis Foundation will develop an ARMS system to monitor vascularized composite...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $573,416 project grant to The Geneva Foundation to conduct a study titled "PRE-DIAGNOSTIC SERUM CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES AND RISK OF TESTICULAR GERM CELL TUMORS AMONG ACTIVE-DUTY SERVICEMEN." The 3-year grant, which began on Sep 30, 2023, will support research investigating the relationship between exposure to per- and polyfluoroalkyl substances...
- The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
- The Defense Health Agency has awarded a $648,097 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 3-year grant, with a period of performance from September 1, 2025 to August 31, 2028, is to conduct research on the relationship between per- and polyfluoroalkyl substances (PFAS) exposure and the risk of thyroid cancer among active component service members...
- The U.S. Defense Health Agency awarded a $715,213 Project Grant to the Veterans Education and Research Association of Northern New England, Inc. (VERANNE) to conduct research on using bile acid-binding resins to decrease systemic per- and polyfluoroalkyl substance (PFAS) levels and improve serum lipid profiles in veterans. This award is part of the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research aimed at transforming healthcare for...